Fig. 2.
Origin and histological subtypes associated with type I and type II molecular classification. [Reproduced from S. Vaughan et al.: Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11:719, 2011 (14), with permission. © Nature Publishing Group.]